Status: Recruiting
Voll Degradable Shoulder Spacer FIH Study
The Voll Degradable Shoulder Spacer First-in-Human study aims to evaluate the initial safety, effectiveness, and clinical outcomes of a degradable shoulder spacer in over 50 years old patients with symptomatic massive rotator cuff tears (MRCT).
Participants needed: 20
Trial details
Age: 50+Biological sex: AllType: InterventionalSponsor: Voll Medical Technologies Ltd.Updated: Mar 6, 2026Locations: 4
Eligibility criteria
Full thickness MRCT. [+1]
Documented evidence of a history of drug/alcohol abuse within 1 year of enrollme... [+1]